Fortis Healthcare Q3 FY26 Revenue Up 17.5% to ₹2,265 Cr, EBITDA Rises 34.8%
Fortis Healthcare reported Q3 FY26 consolidated revenues of ₹2,265 crore, up 17.5% YoY. Operating EBITDA increased 34.8% to ₹505 crore, with margins at 22.3%. Hospital revenues grew 19.4% to ₹1,938 crore. The company acquired People Tree Hospital in Bengaluru for ₹430 crore and launched a mental health facility.
The announcement details significant financial performance improvements, strategic acquisitions, and new business initiatives, which are material to investors and the company's market position.
The company reported strong year-on-year growth in revenues and EBITDA for both consolidated and hospital businesses, along with margin expansion. Strategic acquisitions and new facility launches also indicate positive business development.
Fortis Healthcare Limited has announced its unaudited consolidated financial results for the quarter and nine months ended December 31, 2025. The company reported consolidated revenues of ₹2,265 crore for Q3 FY26, marking a significant 17.5% year-on-year increase. Operating EBITDA saw a substantial rise of 34.8% to ₹505 crore, with the EBITDA margin improving to 22.3% from 19.4% in the same period last year.
Profit Before Tax (before exceptional items) grew by 21.9% YoY to ₹312 crore. The hospital business revenues were robust, growing 19.4% YoY to ₹1,938 crore, with Operating EBITDA increasing by 28.9% to ₹420 crore and the margin improving to 21.7% from 20.0% in Q3 FY25.
The diagnostics business also showed positive performance, with gross revenues up 8.3% to ₹371 crore and Operating EBITDA surging by 73.5% to ₹86 crore, leading to a significant margin expansion to 23.1% from 14.4% in Q3 FY25.
During the quarter, Fortis Healthcare made strategic acquisitions and expansions. In January 2026, the company acquired the 125-bedded People Tree Hospital in Bengaluru for ₹430 crore. In November 2025, it launched ‘Adayu’, a specialized mental health care facility in Gurugram. The company's net debt as of December 31, 2025, stood at ₹2,547 crore.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.